Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 20, 2016 (10 years ago)

HYDROmorphone HCI 0.2mg/ml in 0.9% Sodium Chloride

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

HYDROmorphone HCI 0.2mg/ml in 0.9% Sodium Chloride, 30 mL PCA Vial, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0702-68

Affected NDC 45183-0702-68

Compare with the code on your package — it is the most precise check available.

Drug: Hydromorphone

Recalling firm
Pharmakon Pharmaceuticals, Inc.
NDC code
45183-0702-68
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1293-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydromorphone recalls

See all

Other recalls by Pharmakon Pharmaceuticals, Inc.

All 2016 recalls